Jul. 30 at 1:45 PM
$ETON For those of you worried about pharma tariffs, I don't think Eton is going to be impacted much since it's a orphan drug company with special needs patients. Earnings are within 10 days and likely to beat forecasts due to the better sales. Even better, institutions are starting to take notice and invest, as evidenced by BlackRock announced on July 8. They don't buy loser companies and put their dollars here!
BlackRock, Inc. ownership in ETON / Eton Pharmaceuticals, Inc.
2025-07-17 - BlackRock, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,530,357 shares of Eton Pharmaceuticals, Inc. (US:ETON). This represents 5.7 percent ownership of the company.
